(RTTNews) - Biopharmaceutical company Roche Holding AG (RHHBY), announced on Tuesday that its cobas HPV test for use on the cobas 6800/8800 Systems has been awarded the World Health Organization (WHO) ...

(RTTNews) - Quest Diagnostics (DGX), a diagnostic services provider, announced Wednesday a new FDA-cleared human papillomavirus (HPV) self-collection solution aimed at broadening access to HPV ...

More than 99 percent of cervical cancers are caused by persistent high-risk HPV infection 1 Cervical cancer is nearly 100 percent preventable with proper HPV vaccination, screening and treatment; ...

Let's be honest: Pap smears are terrible. Every year, I stare at the ceiling and try my hardest to ignore the scraping of my insides. In the age of AI chatbots and self-driving cars, how has no one ...

The FDA has approved an alternative to the traditional Pap smear. The U.S. Food and Drug Administration has approved a genetic test from Swiss drug maker Roche as the first U.S.-approved alternative ...

The cobas HPV test detects DNA from 14 high-risk HPV types using a sample of cervical cells, according to the FDA. The test specifically identifies HPV type 16 (HPV16) and HPV type 18 (HPV18), while ...

The first shipments of self-collection HPV tests for cervical cancer screening are making their way to labs and health care facilities across the United States. The Food and Drug Administration gave ...

Roche Diagnostics is looking to a new screening tool to help women learn in a more private way if they are at increased risk for cervical cancer—a self-collection test to identify HPV. With the test, ...

Pelvic exams are no one’s idea of fun. No matter how many you’ve done, no matter how prepared you are, that moment when the ice cold speculum wrenches open your vagina never gets more comfortable. As ...

I'll be the first to admit, getting a Pap smear is one of my least favorite doctor's appointments to schedule. While a crucial aspect of testing for HPV and cervical cancer, the procedure can be very ...